![]() |
14th International AIDS ConferenceBarcelona, Spain — July 7-12, 2002 |
Int Conf AIDS. 2002 Jul 7-12;14:Abstract No. MoOrC1012
BACKGROUND: Few studies have evaluated the impact of acute herpes simplex virus type 2 (HSV-2) infection on HIV acquisition, although a number of studies have identified genital ulcer disease as a major risk factor for HIV infection. We hypothesized that primary genital HSV-2 infection is a critical risk factor for primary HIV infection.
METHODS: A retrospective cohort study of 2732 HIV-1-seronegative patients attending 3 sexually transmitted disease and 1 gynecology clinic, continuously enrolled from 1993-2000 in an ongoing prospective study of acute HIV infection was undertaken in Pune, India. Stored sera were used to establish HSV-2 seroprevalence and seroincidence using the HerpeSelect EIA (Focus Technologies, Cypress, CA). Incident HSV-2 infection was categorized as recent or remote (within the past 6 months or more than 6 months, respectively).
RESULTS: 1175(43%) of the participants were infected with HSV-2 at the baseline visit. Among those initially HSV-2 seronegative, the HSV-2 incidence was 11.4/100py(95% CI 9.9-13.0). Based on a median follow-up time of 11 months, the incidence of HIV-1 was 5.8/100py(95%CI 5.0-6.6). Using a Cox proportional hazards model to adjust for known HIV risk factors, the adjusted relative risk of HIV acquisition associated with chronic (prevalent) HSV-2 infection was 1.69(95%CI 1.23-2.33; p=0.001) and 1.81(95%CI 1.09-3.03; p=.02) with remote primary HSV-2 infection. Recent HSV-2 infection was independently associated with a 3.64-fold increased risk of primary HIV infection(95%CI 1.72-7.70; p<.001).
CONCLUSIONS: Recent HSV-2 infection is a major independent risk factor for acquisition of HIV infection among Indian STD patients. Our findings support the hypothesis that mucosal ulceration from acute HSV-2 infection may be a key biological mechanism which facilitates HIV acquisition. These data also suggest that prevention of primary HSV-2 infection may significantly reduce the risk of HIV infection in this setting.
Presenting author: Steven Reynolds
1Johns Hopkins University, Johns Hopkins University, Division of Infectious Diseases, Ross Building, Room 1150, Baltimore, MD, 21205, United States.
2National AIDS Research Institute, Pune, India.
020708
MoOrC1012
Copyright © 2002 - International AIDS Society (IAS). Reproduction of this abstract (other than one copy for personal reference) must be cleared through the IAS.